nps-568 has been researched along with Low Bone Density in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akizawa, T; Kinugasa, E; Koiwa, F; Ogata, H | 1 |
| Fox, J; Miller, MA | 1 |
1 review(s) available for nps-568 and Low Bone Density
| Article | Year |
|---|---|
CKD-MBD: impact on management of kidney disease.
Topics: Aniline Compounds; Bone Diseases, Metabolic; Calcium Metabolism Disorders; Cardiovascular Diseases; Chelating Agents; Cinacalcet; Disease Progression; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Lanthanum; Naphthalenes; Phenethylamines; Polyamines; Propylamines; Renal Insufficiency, Chronic; Sevelamer; Vitamin D; Vitamin D Deficiency; Vitamins | 2007 |
1 other study(ies) available for nps-568 and Low Bone Density
| Article | Year |
|---|---|
Daily transient decreases in plasma parathyroid hormone levels induced by the calcimimetic NPS R-568 slows the rate of bone loss but does not increase bone mass in ovariectomized rats.
Topics: Aniline Compounds; Animals; Body Weight; Bone Density; Bone Diseases, Metabolic; Calcium; Osteocalcin; Ovariectomy; Parathyroid Hormone; Phenethylamines; Propylamines; Rats; Rats, Sprague-Dawley | 2000 |